These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2558004)

  • 1. RECPAM: a computer program for recursive partition amalgamation for censored survival data and other situations frequently occurring in biostatistics. II. Applications to data on small cell carcinoma of the lung (SCCL).
    Ciampi A; Thiffault J; Sagman U
    Comput Methods Programs Biomed; 1989 Dec; 30(4):283-96. PubMed ID: 2558004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RECPAM: a computer program for recursive partition and amalgamation for censored survival data and other situations frequently occurring in biostatistics. I. Methods and program features.
    Ciampi A; Hogg SA; McKinney S; Thiffault J
    Comput Methods Programs Biomed; 1988; 26(3):239-56. PubMed ID: 3383562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RECPAM: a computer program for recursive partition and amalgamation for survival data and other situations frequently occurring in biostatistics. III. Classification according to a multivariate construct. Application to data on Haemophilus influenzae type b meningitis.
    Ciampi A; du Berger R; Taylor HG; Thiffault J
    Comput Methods Programs Biomed; 1991 Sep; 36(1):51-61. PubMed ID: 1760925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
    Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
    J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
    Paesmans M; Sculier JP; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Sergysels R; Mommen P
    J Clin Oncol; 1995 May; 13(5):1221-30. PubMed ID: 7738625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
    Paesmans M; Sculier JP; Lecomte J; Thiriaux J; Libert P; Sergysels R; Bureau G; Dabouis G; Van Cutsem O; Mommen P; Ninane V; Klastersky J
    Cancer; 2000 Aug; 89(3):523-33. PubMed ID: 10931451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tree-structured prediction for censored survival data and the Cox model.
    Ciampi A; Negassa A; Lou Z
    J Clin Epidemiol; 1995 May; 48(5):675-89. PubMed ID: 7730923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
    Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of histologic subtyping in small cell carcinoma of the lung.
    Choi H; Byhardt RW; Clowry LJ; Almagro UA; Remeniuk E; Holoye PY; Cox JD
    Am J Clin Oncol; 1984 Oct; 7(5):389-97. PubMed ID: 6095638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECPAM analysis of prognostic factors in patients with stage III breast cancer.
    Erlichman C; Warde P; Gadalla T; Ciampi A; Baskerville T
    Breast Cancer Res Treat; 1990 Oct; 16(3):231-42. PubMed ID: 2085674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclassification of small cell cancer of the lung: the Southeastern Cancer Study Group experience.
    Vollmer RT; Birch R; Ogden L; Crissman JD
    Hum Pathol; 1985 Mar; 16(3):247-52. PubMed ID: 2982719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
    Paesmans M; Sculier JP; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Sergysels R; Mommen P; Klastersky J
    Eur J Cancer; 1997 Dec; 33(14):2326-32. PubMed ID: 9616276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patients.
    Sehested M; Hirsch FR; Osterlind K; Olsen JE
    Cancer; 1986 Feb; 57(4):804-7. PubMed ID: 3002587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early assessment of risk for in-hospital death among 11,483 patients with acute myocardial infarction. GISSI investigators.
    Fresco C; Carinci F; Maggioni AP; Ciampi A; Nicolucci A; Santoro E; Tavazzi L; Tognonia G
    Am Heart J; 1999 Dec; 138(6 Pt 1):1058-64. PubMed ID: 10577435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition.
    Sculier JP; Chansky K; Crowley JJ; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2008 May; 3(5):457-66. PubMed ID: 18448996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and prognostic staging system for small cell lung cancer.
    Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
    Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory variables as additional staging parameters in patients with small-cell lung carcinoma. A systematic review.
    Watine J
    Clin Chem Lab Med; 1999 Oct; 37(10):931-8. PubMed ID: 10616746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival in small cell carcinoma of the lung.
    Pallares C; Bastus R; Lopez JJ; De Andres L
    Eur J Cancer Clin Oncol; 1987 May; 23(5):541-4. PubMed ID: 2820739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in small cell carcinoma of the lung--relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens.
    Allan SG; Hay FG; McIntyre MA; Leonard RC
    Br J Cancer; 1987 Oct; 56(4):485-8. PubMed ID: 2825751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.